Continuous Glucose Monitoring for Emergency Laparotomy
CLUE
1 other identifier
interventional
50
1 country
1
Brief Summary
CLUE trial aims to determine the feasibility and predictive value for surgical site infection (SSI) of continuous glucose monitoring (CGM) in emergency laparotomy patients with diffuse peritonitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2022
CompletedFirst Posted
Study publicly available on registry
December 8, 2022
CompletedStudy Start
First participant enrolled
March 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFebruary 2, 2023
February 1, 2023
1.7 years
November 29, 2022
February 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
feasibility of CGM system
measured as the drop-out rate caused by non-adherence of both patients and medical staff due to system detaching, problems with the receiving device (low battery. distance beyond Bluetooth communication range) etc.
10 days
Secondary Outcomes (4)
intra- and post-operative glycemia
10 days
postoperative morbidity
30 days
SSI rate
30 days
effective wound closure
30 days
Study Arms (1)
CGM pre-, intra- and postoperatively
EXPERIMENTALPatients will have a Dexcom G6 system placed on admission on outer part of the arm, glycaemia will be monitored for 10 consecutive days
Interventions
Dexcom G6 system consists of a transmitter and sensor that measure interstitial glycaemia every 5 minutes. Measurements are transmitted via Bluetooth to a compatible device, that uploads the data on a virtual drive. This allows for remote real-time glycaemia monitoring on another device.
Eligibility Criteria
You may qualify if:
- emergency laparotomy for peritonitis
- written informed consent
You may not qualify if:
- \- open abdomen treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCC Division of Oncological, Transplant and General Surgery
Gdansk, Pomeranian Voivodeship, 80952, Poland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Piotr Spychalski, MD, PhD
MUG Division of General Surgery
- PRINCIPAL INVESTIGATOR
Katarzyna Polomska
Medical University of Gdansk (MUG)
- PRINCIPAL INVESTIGATOR
Jaroslaw Kobiela, Prof.
MUG Division of General Surgery
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2022
First Posted
December 8, 2022
Study Start
March 15, 2023
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
February 2, 2023
Record last verified: 2023-02